Bayforest Capital’s Amedisys AMED Stock Holding History

Bayforest Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,111	Closed	-$109K	–	729
2025 Q2	$109K	Sell	1,111 -7,508	-87%	-$710K	0.05%	464
2025 Q1	$798K	Buy	8,619 +6,071	+238%	+$560K	0.35%	66
2024 Q4	$231K	Buy	+2,548	New	+$234K	0.29%	94

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bayforest Capital's AMED Position: Q3 2025 in Review

Bayforest Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,111 shares — an estimated $109K sold.

Bayforest Capital first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $798K in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Bayforest Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Bayforest Capital sold 1,111 Amedisys shares in Q3 2025, an estimated $109K.
Bayforest Capital first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
Bayforest Capital's Amedisys position peaked at $798K in Q1 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bayforest Capital's 13F filing for Q3 2025, filed 24 Oct 2025.